Adult Lymphoma

hematologic malignancy

Identifier: CI-CAN-00000421
Entity page: /cancer/adult-lymphoma ↗
Edges: 362

Neighbours: 99 drugs10 trials
Drawn: 60 of 109 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Adult Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived99 of 99show fewer
→ investigated in trials for	Cyclophosphamidesmall molecule 37 trials (8 active) · roll-up of the cancer and its descendants	—	—	Adult Lymphoma	37	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 36 trials (4 active) · roll-up of the cancer and its descendants

Adult Lymphoma studied in …STUDIED_INderived10 of 263show all (up to 200)
→ studied in	NCT01676805recruiting Tissue Collection for Studies of Lymph Cancer · condition mapped ALIAS · 263 trials mapped (38 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02682667recruiting Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols · condition mapped ALIAS · 263 trials mapped (38 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04301076Phase 1 · recruiting Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) · condition mapped ONTOLOGY_EXACT · 263 trials mapped (38 active)	—	—	Acute Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04938232Phase 2 · active not recruiting Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL · condition mapped ALIAS · 263 trials mapped (38 active)	—	—	Adult Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05798897Phase 1 · recruiting Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma · condition mapped ONTOLOGY_EXACT · 263 trials mapped (38 active)	—	—	Adult Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06421987recruiting Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors · condition mapped ONTOLOGY_EXACT · 263 trials mapped (38 active)	—	—	Adult Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07388563Phase 1 · suspended Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 263 trials mapped (38 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03113500Phase 2 · active not recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 263 trials mapped (38 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07021989Phase 2 · recruiting ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 263 trials mapped (38 active)	—	—	Adult Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00336063Phase 1 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 263 trials mapped (38 active)	—	—	Adult Nasal Type Extranodal NK/T-Cell Lymphoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains